Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Discovery Medicine|December 31, 2009
Screening for EGFR mutations in lung cancerMiguel A Molina-Vila, Jordi Bertran-Alamillo, Clara Mayo, et al.
Current Oncology Reports|May 5, 2020
Correction to: The Present and Future of Liquid Biopsies in Non-Small Cell Lung Cancer: Combining Four Biosources for Diagnosis, Prognosis, Prediction, and Disease MonitoringJillian Wilhelmina Paulina Bracht, Clara Mayo-de-Las-Casas, Jordi Berenguer, et al.
Current Oncology Reports|July 22, 2018
The Present and Future of Liquid Biopsies in Non-Small Cell Lung Cancer: Combining Four Biosources for Diagnosis, Prognosis, Prediction, and Disease MonitoringJillian Wilhelmina Paulina Bracht, Clara Mayo-de-Las-Casas, Jordi Berenguer, et al.
Pharmacogenomics|May 19, 2012
Pharmacogenetics of EGFR in lung cancer: perspectives and clinical applicationsClara Mayo, Jordi Bertran-Alamillo, Miguel Ángel Molina-Vila, et al.
Clinical Lung Cancer|November 6, 2012
KRAS mutations in lung cancerNiki Karachaliou, Clara Mayo, Carlota Costa, et al.
Annals of Translational Medicine|December 24, 2015
cfDNA analysis from blood in melanomaMiguel A Molina-Vila, Clara Mayo de-Las-Casas, Jordi Bertran-Alamillo, et al.
Translational Lung Cancer Research|November 10, 2016
KRAS mutations in the circulating free DNA (cfDNA) of non-small cell lung cancer (NSCLC) patientsMónica Garzón, Sergi Villatoro, Cristina Teixidó, et al.
International Journal of Cancer|May 4, 2006
Methotrexate resistance in vitro is achieved by a dynamic selectionprocess of tumor cell variants emerging during treatmentJosep M de Anta, Clara Mayo, Francesc Solé, et al.
Pageof 5